Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of Various Potencies of an Investigational Varicella Vaccine in Healthy Children
NCT05084508Phase 2Completed
- Sponsor
- GSK
- Start
- Feb 2022
- Primary completion
- Feb 2024
- Modality
- Prophylactic Vaccines, DNA Vaccines, Live Biotherapeutic Products
- Countries
- 6
01
Overview
A Phase 2 trial of Investigational varicella vaccine in chickenpox, sponsored by GSK. Started Feb 2022; status: completed.
02
Drugs
Investigational varicella vaccine
03
Conditions
chickenpox
Beyond the preview
Go deeper on NCT05084508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05084508.